The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
暂无分享,去创建一个
B. Davis | M. Pfeffer | J. Rouleau | E. Braunwald | F. Sacks | E. Braunwald | J. Arnold | C. Wun | T. Cole | L. Moyé | J. Rutherford | L. Brown | J. Warnica | L. Moye | Marc A. Pfeffer | Lemuel A. Moye | Jean L. Rouleau | Thomas G. Cole | Lisa Brown | J. Wayne Warnica | J. Malcolm O. Arnold | Eugene Braunwald
[1] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .
[2] C. Furberg,et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. , 1995, Circulation.
[3] J. Salonen,et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. , 1995, Circulation.
[4] B. Rosner,et al. The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials , 1995 .
[5] W. Kannel. Range of serum cholesterol values in the population developing coronary artery disease. , 1995, The American journal of cardiology.
[6] I. Holme. Cholesterol reduction and its impact on coronary artery disease and total mortality. , 1995, The American journal of cardiology.
[7] M. Pfeffer,et al. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. , 1995, The American journal of cardiology.
[8] J. Rossouw. Lipid-lowering interventions in angiographic trials. , 1995, The American journal of cardiology.
[9] T. Wilt,et al. Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. , 1995, The American journal of cardiology.
[10] Gram Jb,et al. The Scandinavian Simvastatin Survival Study (4S) , 1995 .
[11] C. Furberg,et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.
[12] B. Rosner,et al. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients , 1994, The Lancet.
[13] C. Furberg,et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.
[14] A. Dobs,et al. Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. , 1993, Metabolism: clinical and experimental.
[15] D. Gordon,et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. , 1993, JAMA.
[16] K. Anderson,et al. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. , 1992, Journal of the American College of Cardiology.
[17] J. Buring,et al. Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction , 1992, Circulation.
[18] M. Pfeffer,et al. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE) , 1991, The American journal of cardiology.
[19] C. Lavie,et al. National Cholesterol Education Program's recommendations, and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs. , 1991, The American journal of cardiology.
[20] J Pekkanen,et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.
[21] L. Kuller,et al. SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.
[22] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[23] H. Keen,et al. MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE , 1977, The Lancet.
[24] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[25] D. Cox. Regression Models and Life-Tables , 1972 .
[26] U. Tomiyasu,et al. A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis , 1969 .